Hologic Inc (HOLX)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$74.66

Buy

$75.00

arrow-up$0.17 (+0.23%)

Prices updated at 12 Dec 2025, 22:57 EST

Prices minimum 15 mins delay

Prices in USD

Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Its products are used in diagnosis of human diseases and screen donated human blood and plasma.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Stephen P. Macmillan

CEO

Mr. Stephen P. Macmillan

Most recent earnings

30 Sep 2025

Fiscal year end

30 Sep 2025

Employees

7,070

Head office

250 Campus Drive

Marlborough

United States

01752

+1 508 263-2900

michael.watts@hologic.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Charles J. Dockendorff Independent Director	0.12m
Mr. Scott T. Garrett Independent Director	0.11m
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President	1.21m
Dr. Martin D. Madaus,PhD Director	-
Ms. Sally Wellinghoff Crawford Independent Director	0.12m
Ms. Amy A. Wendell Lead Independent Director	0.12m
Ms. Karleen M. Oberton Chief Financial Officer	0.69m
Ms. Stacey D. Stewart Independent Director	0.09m
Dr. Ludwig N. Hantson, PhD Independent Director	0.09m
Ms. Christiana Stamoulis, M.B.A. Independent Director	0.09m
Mr. Benjamin J. Cohn Vice President, Corporate Controller and Principal Accounting Officer	-
Mr. Wayde D. McMillan Director	-
Ms. Nanaz Mohtashami Independent Director	0.09m
Ms. Diana De Walt Senior Vice President, Human Resources	-
Mr. Essex D. Mitchell Chief Operating Officer	0.59m
Mr. Jan Verstreken Group President, International	0.69m
Ms. Jennifer Schneiders President, Diagnostics Solutions	-
Mr. Brandon Schnittker Division President, GYN Surgical Solutions	-
Mr. Mark Horvath Division President, Breast and Skeletal Health Solutions	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	26,801,683
T. Rowe Price Investment Management,Inc.	21,549,648
BlackRock Inc	19,413,701
T. Rowe Price	13,480,739
Manufacturers Life Insurance Co	10,450,448

Director dealings

Date chevron-l-regular chevron-r-regular	Action
13 Dec 2024	-
09 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
04 Dec 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-
14 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.